Tretoquinol is a synthetic cardiovascular drug categorized as a beta-adrenergic agonist and phosphodiesterase inhibitor, primarily utilized for its bronchodilator and vasodilatory effects in the management… Read more
Tretoquinol is a synthetic cardiovascular drug categorized as a beta-adrenergic agonist and phosphodiesterase inhibitor, primarily utilized for its bronchodilator and vasodilatory effects in the management of respiratory conditions and hypertension. Analytical laboratories require high-quality reference standards for this compound to ensure accurate impurity profiling and precise quantification during pharmaceutical development. This category includes the active pharmaceutical ingredient, potential process-related impurities such as N-nitroso derivatives, and stable isotope labelled compounds like deuterated tretoquinol analogues. These deuterated standards act as internal standards in liquid chromatography-mass spectrometry (LC-MS) assays, allowing for the reliable validation of analytical methods and consistent quality control of the parent drug throughout its manufacturing lifecycle. By utilizing these certified reference materials, researchers can effectively identify and mitigate trace contaminants while verifying the chemical stability and purity of tretoquinol formulations.